Netherlands / Argenx to Go it Alone; Agendia Backs Out of IPO; Pleco AML Financing
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…